Emerging therapy for endometriosis

Expert Opinion on Emerging Drugs

Volumn 20, Issue 3, 2015, Pages 449-461

  Lindsay, Sarah F ^a   Luciano, Danielle E ^a   Luciano, Anthony A ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

aromatase inhibitor; combined hormonal contraceptive; endometriosis; gonadotropin releasing hormone agonist; gonadotropin releasing hormone antagonist; levonorgesterol intrauterine system; nonsteroidal anti inflammatory drug; progesterone antagonist; progestins; selective estrogen receptor modulator; selective progesterone receptor modulator; vascular endothelial growth factor

Indexed keywords

ANTIGESTAGEN; AROMATASE INHIBITOR; CONTRACEPTIVE AGENT; DANAZOL; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE RECEPTOR MODULATOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; CLINICAL EFFECTIVENESS; DRUG MARKETING; ENDOMETRIOSIS; HUMAN; LONG TERM CARE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANALGESIA; ANIMAL; COMPLICATION; DRUG DESIGN; FEMALE; INFERTILITY, FEMALE; MULTIMODALITY CANCER THERAPY; PAIN; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; COMBINED MODALITY THERAPY; DRUG DESIGN; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; PAIN; PAIN MANAGEMENT;

EID: 84940396497     PISSN: 14728214     EISSN: 17447623     Source Type: Journal    
DOI: 10.1517/14728214.2015.1051966     Document Type: Article

References (67)

1. Burney RO, Guidice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98(3): 511-19
2. Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term Dienogest treatment. Arch Gynecol Obstet 2012; 285(1): 167-73
3. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011; 118(3): 691-705
4. Carvalho L, Podgaec S, Bellodi-Privato M, et al. Role of eutopic endometrium in pelvic endometriosis. J Minim Invasive Gynecol 2011; 18(4): 419-27
5. Meresman GF, Auge L, Baranao RI, et al. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002; 77(6): 1141-7
6. Beliard A, Agnes N, Foidart J-M. Reduction of apoptosis and proliferation in endometriosis. Fertil Steril 2004; 82(1): 80-5
7. Chwalisz K, Perez MC, DeMannon D, et al. Selective progesterone receptor modulator development and Use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005; 26(3): 423-38
8. Santulli P, Borghese B, Noel JC, et al. Hormonal therapy deregulates prostaglandin-endoperoxidase synthase 2 (PTGS2) expression in endometriotic tissues. J Clin Endocrinol Metab 2014; 99(3): 881-90
9. Dassen H, Punyadeera C, Kamps R, et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007; 22(12): 3148-58
10. Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160(8): 784-96
11. Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006; 21(1): 248-56
12. Gomes MKO, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009; 24(11): 2736-45
13. Luciano A. Danazol treatment of endometriosis-associated pain J Minim Invasive Gynecol 2006; 13(6): 523-4
14. Razzi S, Luisi S, Calonaci F, et al. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007; 88(4): 789-94
15. Cobellis L, Razzi S, Fava A, et al. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril 2004; 82(1): 239-40
16. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal antiinflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2009; 2(11): 1-19
17. Cobellis L, Razzi S, De Simone S, et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol and Reprod Biol 2004; 116(1): 100-2
18. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th edition. Lippincott Williams & Wilkins; 2004
19. Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of painsymptoms associated with endometriosis, a randomized, double blind multicenter, controlled trial. Fertil Steril 2009; 91(3): 675-81
20. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: A 24-week, randomized, multicentre open-label trial. Hum Reprod 2010; 25(3): 633-41
21. Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, et al. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain. Obstet Gynecol 2012; 119(3): 519-26
22. Vercellini P, Crosignani PG, Somigliana E, et al. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod 2009; 24(10): 2504-14
23. Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005; 20(7): 1993-8
24. Carr B, Dmowski WP, O'Brien C, et al. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: Effects on Bone Mineral Density. Reprod Sci 2014; 21(11): 1341-51
25. Bayoglu Tekin Y, Dilbaz B, Kiykac Altinbas SK, Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropinreleasing hormone analogue. Fertil Steril 2011; 95(2): 492-6
26. Vercellini P, Frontino G, De Giorgi O, et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003; 80(3): 560-3
27. The Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2008; 90(3): S260-S69
28. Seracchioli R, Mabrouk M, Frasca C, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrance: A randomized controlled trial. Fertil Steril 2010; 93(1): 52-6
29. Vlahos N, Vlachos A, Triantafyllidou O, et al. Continous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: A prospective cohort study. Fertil Steril 2013; 100(5): 1337-42
30. Vercellini P, Somigliana E, Daguati R, et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet and Gynecol 2008; 198(5): 504-6
31. Chapron C, Souza C, Borghese B, et al. Oral contraceptives and endometriosis: The past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011; 26(8): 2028-35
32. Centers for Disease Control. U. S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep 2010; 18(59): 1-86
33. Zupi E, Marconi D, Sbracia M, et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril 2004; 82(5): 1303-8
34. Franke HR, van de Weijer PHM, Pennings TMM, van der Mooren MJ. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: A prospective, randomized, placebocontrolled, double-blind trial. Fertil Steril 2000; 74(3): 534-9
35. Paoletti AM, Serra GC, Cagnacci A, et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996; 65(4): 707-10
36. Guzick DS, Huang L-S, Broadman BA, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011; 95(5): 1568-73
37. Diamond MP, Carr B, Dmowski WP, et al. Elagolix treatment for endometriosis-associated pain: Results from a Phase 2, Randomized, Double-Blind, placebo-controlled Study. Reprod Sci 2014; 21(2): 363-71
38. Jacobson TZ, Duffy JM, Barlow D, et al. Laparoscopic surgery for pelvic pain associated with endometriosis (Review). Cochrane Database Syst Rev 2009; 7(4): 1-28
39. Alborzi S, Hamedi B, Omidvar A, et al. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol and Obstet 2011; 284(1): 105-10
40. Abou-Setta AM, Houston B, Al-Inany HG, Farquar C. Levonorgestrel intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013; 1: 1-33
41. Serracchioli R, Mabrouk M, Frasca C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: A randomized controlled trial. Fertil Steril 2010; 94(2): 464-71
42. Somigliana E, Vercellini P, Vigano P, et al. Postoperative medical therapy after surgical treatment of endometriosis: From adjuvant therapy to tertiary prevention. J Minim Invasive Gynecol 2014; 21(3): 328-34
43. Ferrero S, Camerini G, Seracchiolo R, et al. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 2009; 24(12): 3033-41
44. Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: A prospective randomized trial. Hum Reprod 2004; 19(1): 160-7
45. Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998; 69(4): 709-13
46. Fatemi H, Al-Turki H, Papanikolaou E, et al. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod BioMedicine Online 2005; 11(4): 455-7
47. Mousa N, Bedaiwy M, Casper R. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007; 109(6): 1421-3
48. Remorgida V, Abbamonte LH, Ragni N, et al. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynecol 2007; 47(3): 222-5
49. Abushahin F, Goldman KN, Barbieri E, et al. Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril 2011; 96(4): 939-42
50. Ferrero S, Venturini PL, Gillott DJ, Remorgida V. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: A randomized controlled trial. Reprod Biol Endocrinol 2011; 9(88): 1-7
51. Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrozole and oral contraceptives: A novel treatment for endometriosis. Fertil Steril 2005; 84(2): 300-4
52. Mei L, Bao J, Tang L, et al. A novel mifepristone-loaded implant for longterm treatment of endometriosis: In vitro and in vivo studies. Eur J Pharm Sci 2010; 39(2010): 421-7
53. Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012; 366(5): 421-32
54. Chwalisz K, Elger W, Stickler T, et al. The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Hum Reprod 2005; 20(4): 1090-9
55. Bouchard P, Chabbert-Buffet N, Gauser BCJM. Selective progesterone receptor modulators in reproductive medicine: Pharmacology, clinical efficacy, and safety. Fertil Steril 2011; 96(5): 1175-89
56. Kettel L, Murphy A, Morales A, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 1996; 65(1): 23-8
57. Mutter GL, Bergeron C, Deligdisch L, et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 2008; 21(5): 591-8
58. Kulak Jr J, Fischer C, Komm B, Taylor HS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 2011; 152(8): 3226-32
59. Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment. Obstet Gynecol 2008; 111(1): 88-96
60. Naqvui H, Sakr S, Presti T, et al. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model. Biol Reprod 2014; 90(6): 1-7
61. Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanism of action and clinical applications. Hum Reprod Update 2005; 11(3): 293-307
62. The Practice Committee of the American Society of Reproductive Medicine. Endometriosis and Infertility: A committee opinion. Fertil Steril 2012; 98(3): 591-8
63. Sallam NH, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary downregulation before in vitro fertilization (IVF) for women with endometriosis (Review). Cochrane Database Syst Rev 2006; 1: 1-19
64. de Ziegler D, Gayet V, Aubriot FX, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010; 94(7): 2796-9
65. Macer ML, Taylor HS. Endometriosis and infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012; 39(4): 535-49
66. Johnson NP, Hummelshoj L. World endometriosis society montpellier consortium consensus on current management of endometriosis. Hum Reprod 2013; 28(6): 1552-68
67. Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: A pilot study. Fertil Steril 2004; 81 (2): 290-6